A CAR-T deal in China; Zevra’s $60M offering
Plus, news about Arrowhead, Cullinan Therapeutics, Cytokinetics, Zentalis, Inovio and Mind Medicine:
Domestic biotech M&A in China: Northeast Pharmaceutical Group, a decades-old maker of generics …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.